Demographic and clinical characteristics of study patients
| Characteristics | Gout patients (n=40) | Controls (n=40) |
|---|---|---|
| Age (years), mean | 62 | 53 |
| Male subjects, N (%) | 35 (87.5) | 13 (33) |
| Body mass index (kg/m2) | 29.6 | 26.5 |
| Duration of gout or control arthritis (years), mean | 13 | 11 |
| History of urate lowering therapy, N (%) | 35 (87.5) | 0 (0) |
| Serum uric acid level (µmol/l), mean (mg/dl) | 374 (6.3) | 337 (5.7) |
| Number of gout flares during the past year, N (%) | ||
| 0–1 | 3 (7.5) | – |
| 2–3 | 27 (67.5) | – |
| ≥4 | 10 (25.0) | – |
| Time since the last gout attack, N (%) | ||
| <1 week | 7 (17.5) | – |
| 1–4 weeks | 15 (37.5) | – |
| 1–4 months | 9 (22.5) | – |
| >4 months | 9 (22.5) | – |